Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19 : a study in a large multihospital institution in the Paris region
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved..
OBJECTIVES: This study measured the impact of the first wave of COVID-19 pandemic (COVID-19) (March-April 2020) on the incidence of bloodstream infections (BSIs) at Assistance Publique - Hôpitaux de Paris (APHP), the largest multisite public healthcare institution in France.
METHODS: The number of patient admission blood cultures (BCs) collected, number of positive BCs, and antibiotic resistance and consumption were analysed retrospectively for the first quarter of 2020, and also for the first quarter of 2019 for comparison, in 25 APHP hospitals (ca. 14 000 beds).
RESULTS: Up to a fourth of patients admitted in March-April 2020 in these hospitals had COVID-19. The BSI rate per 100 admissions increased overall by 24% in March 2020 and 115% in April 2020, and separately for the major pathogens (Escherichia coli, Klebsiella pneumoniae, enterococci, Staphylococcus aureus, Pseudomonas aeruginosa, yeasts). A sharp increase in the rate of BSIs caused by microorganisms resistant to third-generation cephalosporins (3GC) was also observed in March-April 2020, particularly in K. pneumoniae, enterobacterial species naturally producing inducible AmpC (Enterobacter cloacae...), and P. aeruginosa. A concomitant increase in 3GC consumption occurred.
CONCLUSIONS: The COVID-19 pandemic had a strong impact on hospital management and also unfavourable effects on severe infections, antimicrobial resistance, and laboratory work diagnostics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
|---|---|
| Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 114(2022) vom: 15. Jan., Seite 90-96 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Amarsy, Rishma [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 04.01.2022 Date Revised 04.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijid.2021.10.034 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332290506 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332290506 | ||
| 003 | DE-627 | ||
| 005 | 20231225215303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2021.10.034 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332290506 | ||
| 035 | |a (NLM)34688945 | ||
| 035 | |a (PII)S1201-9712(21)00821-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Amarsy, Rishma |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19 |b a study in a large multihospital institution in the Paris region |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2022 | ||
| 500 | |a Date Revised 04.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a OBJECTIVES: This study measured the impact of the first wave of COVID-19 pandemic (COVID-19) (March-April 2020) on the incidence of bloodstream infections (BSIs) at Assistance Publique - Hôpitaux de Paris (APHP), the largest multisite public healthcare institution in France | ||
| 520 | |a METHODS: The number of patient admission blood cultures (BCs) collected, number of positive BCs, and antibiotic resistance and consumption were analysed retrospectively for the first quarter of 2020, and also for the first quarter of 2019 for comparison, in 25 APHP hospitals (ca. 14 000 beds) | ||
| 520 | |a RESULTS: Up to a fourth of patients admitted in March-April 2020 in these hospitals had COVID-19. The BSI rate per 100 admissions increased overall by 24% in March 2020 and 115% in April 2020, and separately for the major pathogens (Escherichia coli, Klebsiella pneumoniae, enterococci, Staphylococcus aureus, Pseudomonas aeruginosa, yeasts). A sharp increase in the rate of BSIs caused by microorganisms resistant to third-generation cephalosporins (3GC) was also observed in March-April 2020, particularly in K. pneumoniae, enterobacterial species naturally producing inducible AmpC (Enterobacter cloacae...), and P. aeruginosa. A concomitant increase in 3GC consumption occurred | ||
| 520 | |a CONCLUSIONS: The COVID-19 pandemic had a strong impact on hospital management and also unfavourable effects on severe infections, antimicrobial resistance, and laboratory work diagnostics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antibiotic consumption | |
| 650 | 4 | |a Antimicrobial resistance | |
| 650 | 4 | |a Blood culture | |
| 650 | 4 | |a Bloodstream infection incidence | |
| 650 | 4 | |a COVID-19 | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Trystram, David |e verfasserin |4 aut | |
| 700 | 1 | |a Cambau, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Monteil, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Fournier, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Oliary, Juliette |e verfasserin |4 aut | |
| 700 | 1 | |a Junot, Helga |e verfasserin |4 aut | |
| 700 | 1 | |a Sabatier, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Porcher, Raphaël |e verfasserin |4 aut | |
| 700 | 1 | |a Robert, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Jarlier, Vincent |e verfasserin |4 aut | |
| 700 | 0 | |a “la Collégiale de Bactériologie–Virologie–Hygiène de l'Assistance Publique – Hôpitaux de Paris” |e verfasserin |4 aut | |
| 700 | 1 | |a Arlet, Guillaume |e investigator |4 oth | |
| 700 | 1 | |a Lefevre, Laurence Armand |e investigator |4 oth | |
| 700 | 1 | |a Aubry, Alexandra |e investigator |4 oth | |
| 700 | 1 | |a Belec, Laurent |e investigator |4 oth | |
| 700 | 1 | |a Bercot, Béatrice |e investigator |4 oth | |
| 700 | 1 | |a Bonacorsi, Stéphane |e investigator |4 oth | |
| 700 | 1 | |a Calvez, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Cambau, Emmanuelle |e investigator |4 oth | |
| 700 | 1 | |a Carbonnelle, Etienne |e investigator |4 oth | |
| 700 | 1 | |a Chevaliez, Stéphane |e investigator |4 oth | |
| 700 | 1 | |a Decousser, Jean-Winoc |e investigator |4 oth | |
| 700 | 1 | |a Delaugerre, Constance |e investigator |4 oth | |
| 700 | 1 | |a Descamps, Diane |e investigator |4 oth | |
| 700 | 1 | |a Doucet-Populaire, Florence |e investigator |4 oth | |
| 700 | 1 | |a Gaillard, Jean-Louis |e investigator |4 oth | |
| 700 | 1 | |a Chenon, Antoine Garbarg- |e investigator |4 oth | |
| 700 | 1 | |a Gault, Elyanne |e investigator |4 oth | |
| 700 | 1 | |a Herrmann, Jean-Louis |e investigator |4 oth | |
| 700 | 1 | |a Jarlier, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Goff, Jérôme Le |e investigator |4 oth | |
| 700 | 1 | |a Lucet, Jean-Christophe |e investigator |4 oth | |
| 700 | 1 | |a Mainardi, Jean-Luc |e investigator |4 oth | |
| 700 | 1 | |a Marcellin, Anne-Geneviève |e investigator |4 oth | |
| 700 | 1 | |a Morand-Joubert, Laurence |e investigator |4 oth | |
| 700 | 1 | |a Nassif, Xavier |e investigator |4 oth | |
| 700 | 1 | |a Pawlotsky, Jean-Michel |e investigator |4 oth | |
| 700 | 1 | |a Robert, Jérôme |e investigator |4 oth | |
| 700 | 1 | |a Afonso, Anne-Marie Roque |e investigator |4 oth | |
| 700 | 1 | |a Rottman, Martin |e investigator |4 oth | |
| 700 | 1 | |a Rouzioux, Christine |e investigator |4 oth | |
| 700 | 1 | |a Rozenberg, Flore |e investigator |4 oth | |
| 700 | 1 | |a Simon, François |e investigator |4 oth | |
| 700 | 1 | |a Veziris, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Skurnik, David |e investigator |4 oth | |
| 700 | 1 | |a Zahar, Jean-Ralph |e investigator |4 oth | |
| 700 | 1 | |a Barnaud, Guilene |e investigator |4 oth | |
| 700 | 1 | |a Pomares, Typhaine Billard |e investigator |4 oth | |
| 700 | 1 | |a Cuzon, Gaëlle |e investigator |4 oth | |
| 700 | 1 | |a Decré, Dominique |e investigator |4 oth | |
| 700 | 1 | |a Doloy, Alexandra |e investigator |4 oth | |
| 700 | 1 | |a Donay, Jean-Luc |e investigator |4 oth | |
| 700 | 1 | |a Drieux-Rouzet, Laurence |e investigator |4 oth | |
| 700 | 1 | |a Durand, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Ferroni, Agnès |e investigator |4 oth | |
| 700 | 1 | |a Fihman, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Fortineau, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Gomart, Camille |e investigator |4 oth | |
| 700 | 1 | |a Grall, Nathalie |e investigator |4 oth | |
| 700 | 1 | |a Caruba, Christelle Guillet |e investigator |4 oth | |
| 700 | 1 | |a Jaureguy, Françoise |e investigator |4 oth | |
| 700 | 1 | |a Lalande, Valérie |e investigator |4 oth | |
| 700 | 1 | |a Landraud, Luce |e investigator |4 oth | |
| 700 | 1 | |a Leflon, Véronique |e investigator |4 oth | |
| 700 | 1 | |a Mariani, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Mihaila, Liliana |e investigator |4 oth | |
| 700 | 1 | |a Moissenet, Didier |e investigator |4 oth | |
| 700 | 1 | |a Noussair, Latifa |e investigator |4 oth | |
| 700 | 1 | |a Podglajen, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Poilane, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Poupet, Hélène |e investigator |4 oth | |
| 700 | 1 | |a Rondinaud, Emilie |e investigator |4 oth | |
| 700 | 1 | |a Tardy, Valérie Sivadon |e investigator |4 oth | |
| 700 | 1 | |a Trystram, David |e investigator |4 oth | |
| 700 | 1 | |a Verdet, Charlotte |e investigator |4 oth | |
| 700 | 1 | |a Vigier, Emmanuelle |e investigator |4 oth | |
| 700 | 1 | |a Billarant, Sophie Vimont |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 114(2022) vom: 15. Jan., Seite 90-96 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
| 773 | 1 | 8 | |g volume:114 |g year:2022 |g day:15 |g month:01 |g pages:90-96 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2021.10.034 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 114 |j 2022 |b 15 |c 01 |h 90-96 | ||